Terrance Williams - Encompass Health Independent Director
| EHC Stock | USD 85.86 0.25 0.29% |
Insider
Terrance Williams is Independent Director of Encompass Health Corp since 2020.
| Age | 52 |
| Tenure | 4 years |
| Address | 9001 Liberty Parkway, Birmingham, AL, United States, 35242 |
| Phone | 205 967 7116 |
| Web | https://www.encompasshealth.com |
Terrance Williams Latest Insider Activity
Tracking and analyzing the buying and selling activities of Terrance Williams against Encompass Health stock is an integral part of due diligence when investing in Encompass Health. Terrance Williams insider activity provides valuable insight into whether Encompass Health is net buyers or sellers over its current business cycle. Note, Encompass Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Encompass Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Terrance Williams over three months ago Acquisition by Terrance Williams of tradable shares of Encompass Health subject to Rule 16b-3 | ||
Terrance Williams over six months ago Acquisition by Terrance Williams of tradable shares of Encompass Health subject to Rule 16b-3 | ||
Terrance Williams over six months ago Acquisition by Terrance Williams of tradable shares of Encompass Health subject to Rule 16b-3 | ||
Terrance Williams over a year ago Acquisition by Terrance Williams of 2385 shares of Encompass Health subject to Rule 16b-3 |
Encompass Health Management Efficiency
The company has Return on Asset of 0.0794 % which means that on every $100 spent on assets, it made $0.0794 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2294 %, implying that it generated $0.2294 on every 100 dollars invested. Encompass Health's management efficiency ratios could be used to measure how well Encompass Health manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 0.22, whereas Return On Tangible Assets are forecasted to decline to 0.05. At present, Encompass Health's Deferred Long Term Asset Charges is projected to decrease significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.46, whereas Total Assets are forecasted to decline to about 3.8 B.Similar Executives
| Showing other executives | INSIDER Age | ||
| J Abernathy | National HealthCare | 83 | |
| Heath Sampson | ModivCare | 53 | |
| Rob Borella | InnovAge Holding Corp | N/A | |
| Liping Zhang | Concord Medical Services | 48 | |
| Diane Kumarich | Addus HomeCare | N/A | |
| Robin Doerr | InnovAge Holding Corp | 60 | |
| Jennifer CPA | Pennant Group | 55 | |
| Maria Lozzano | InnovAge Holding Corp | 44 | |
| Ryan Kubota | InnovAge Holding Corp | N/A | |
| Kevin Ellich | ModivCare | N/A | |
| Olivia Patton | InnovAge Holding Corp | N/A | |
| Xun Liu | Concord Medical Services | N/A | |
| Laurence Harrod | Acadia Healthcare | 67 | |
| Joel Veit | Select Medical Holdings | N/A | |
| Derek Bunker | Pennant Group | 36 | |
| John Gochnour | Pennant Group | 41 | |
| Walt Meffert | ModivCare | 60 | |
| W Adams | National HealthCare | 73 | |
| RN MHA | InnovAge Holding Corp | 62 | |
| LLM JD | ModivCare | 54 | |
| Robby Stevenson | Addus HomeCare | 44 | |
Management Performance
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0794 |
Encompass Health Corp Leadership Team
Elected by the shareholders, the Encompass Health's board of directors comprises two types of representatives: Encompass Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Encompass. The board's role is to monitor Encompass Health's management team and ensure that shareholders' interests are well served. Encompass Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Encompass Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christopher Reidy, Independent Director | ||
| John Darby, General VP | ||
| Jerry Gray, President Region | ||
| John Chidsey, Independent Director | ||
| Nancy Schlichting, Independent Director | ||
| Yvonne Curl, Independent Director | ||
| Leo Higdon, Non-Executive Independent Chairman of the Board | ||
| Andrew Price, Chief Accounting Officer | ||
| Mark Tarr, President, Chief Executive Officer, Director | ||
| Gregory Carmichael, Independent Director | ||
| Anthony Hernandez, Chief Human Resource Officer | ||
| Kevin Connor, Independent Director | ||
| Dawn Rock, Chief Officer | ||
| Linda Wilder, President Region | ||
| Elissa Charbonneau, Chief Medical Officer | ||
| Edmund Fay, Senior Vice President Treasurer | ||
| Joan Herman, Independent Director | ||
| Patricia Maryland, Independent Director | ||
| Charles Elson, Independent Director | ||
| L Shaw, Independent Director | ||
| Melanie Lewis, Senior Vice President Chief Business Development Officer | ||
| Peter Mantegazza, President Region | ||
| MS DO, Chief Officer | ||
| Mark Miller, Senior Vice President of Investor Relations | ||
| Terrance Williams, Independent Director | ||
| April Anthony, Chief Executive Officer and President - Encompass | ||
| Patrick Darby, Executive Vice President General Counsel, Secretary | ||
| Barbara Jacobsmeyer, Executive Vice President and President - Inpatient Hospitals | ||
| Frank Brown, President Region | ||
| Leslye Katz, Independent Director | ||
| Rusty Yeager, Chief VP | ||
| Donald Correll, Independent Director | ||
| John Maupin, Independent Director | ||
| Douglas Coltharp, Chief Financial Officer, Executive Vice President |
Encompass Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Encompass Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0794 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 12.12 B | ||||
| Shares Outstanding | 100.69 M | ||||
| Shares Owned By Insiders | 1.43 % | ||||
| Shares Owned By Institutions | 99.59 % | ||||
| Number Of Shares Shorted | 1.77 M | ||||
| Price To Earning | 18.73 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Encompass Health Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Encompass Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Encompass Health Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Encompass Health Corp Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Encompass Health Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Encompass Health Corp information on this page should be used as a complementary analysis to other Encompass Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Encompass Stock analysis
When running Encompass Health's price analysis, check to measure Encompass Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Encompass Health is operating at the current time. Most of Encompass Health's value examination focuses on studying past and present price action to predict the probability of Encompass Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Encompass Health's price. Additionally, you may evaluate how the addition of Encompass Health to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Encompass Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Encompass Health. If investors know Encompass will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Encompass Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.266 | Dividend Share 0.6 | Earnings Share 3.82 | Revenue Per Share 49.767 | Quarterly Revenue Growth 0.134 |
The market value of Encompass Health Corp is measured differently than its book value, which is the value of Encompass that is recorded on the company's balance sheet. Investors also form their own opinion of Encompass Health's value that differs from its market value or its book value, called intrinsic value, which is Encompass Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Encompass Health's market value can be influenced by many factors that don't directly affect Encompass Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Encompass Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Encompass Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Encompass Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.